Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
“Am I a good candidate for a hair transplant?” is a more important question than “Which technique should I choose?” or “How many grafts do I need?” A transplant can move suitable hair from one part of the scalp to another, but it cannot create an unlimited donor supply, stop every type of hair loss or guarantee the density you once had.
A strong candidate usually has a clear diagnosis, a sufficiently stable pattern of hair loss, a healthy and usable donor area, realistic expectations and no untreated condition likely to compromise surgery or healing. A weak candidate may still become suitable later, but only after the cause of hair loss has been investigated, active disease has settled, medical risks have been addressed or the long-term plan has changed.
This guide explains how doctors assess hair transplant suitability in men and women. It covers age, donor density, miniaturisation, medical conditions, medications, scalp disorders, psychological readiness and the differences between being technically operable and being likely to benefit.
Quick answer: you may be a good hair transplant candidate if your hair loss has been diagnosed, your donor hair appears resistant and sufficient for the proposed area, your scalp is healthy, your general health permits elective surgery and your expectations match what your lifetime donor supply can realistically achieve. Photographs and online questionnaires can help with preliminary screening, but they cannot confirm candidacy.
There is no single test that produces a simple yes or no. Suitability is the combined result of several findings:
| More favourable signs | Needs further assessment or stabilisation | Often unsuitable until the issue is resolved |
|---|---|---|
| Confirmed pattern hair loss | Rapid recent shedding | Uncertain diagnosis |
| Stable, dense donor zone | Early donor miniaturisation | Diffuse unpatterned alopecia |
| Healthy scalp | Previous scalp surgery or scarring | Active inflammatory or scarring disease |
| Realistic coverage goals | Very young patient with evolving loss | Expectation of original teenage density |
| Medically fit for elective surgery | Condition requiring medical clearance | Uncontrolled health or bleeding risk |
| Accepts future treatment may be needed | Uncertain willingness to use ongoing treatment | Severe untreated body-image distress |
This table is only a framework. A favourable sign does not guarantee a good result, and a concern does not automatically mean permanent exclusion. A dermatologist or appropriately qualified hair-restoration doctor needs to interpret the complete picture.
Hair transplantation is a redistribution procedure, not a diagnosis. Before discussing extraction methods, the clinician should determine whether the loss is androgenetic, inflammatory, autoimmune, traction-related, temporary, scar-related or caused by another medical process.
A transplant placed into the wrong condition can fail to address the real problem. In some disorders it can also expose the patient to poor growth, continued shedding or disease activity around the grafts.
Male- and female-pattern hair loss, also called androgenetic alopecia, is the most common indication for scalp hair transplantation. The usual principle is that selected follicles from a more resistant donor zone retain enough of their characteristics after relocation to grow in the recipient area.
Pattern hair loss can still progress in the non-transplanted hair. This is why a diagnosis of androgenetic alopecia is not sufficient on its own. The clinician must also examine the donor area, estimate the future pattern and decide whether surgery, medical management or a combination is most appropriate.
Men are often described with the Hamilton–Norwood scale, while female-pattern loss may be described with the Ludwig or Sinclair classifications. These systems help communicate the visible pattern; they do not automatically determine candidacy or graft count. Our graft and Norwood scale guide explains this distinction in more detail.
Some people have a naturally high forehead, pronounced temporal recessions or an uneven hairline without progressive baldness. Selected patients may be candidates for hairline advancement with grafts, but the assessment still needs to consider age, facial proportions, donor supply and whether apparently stable recession is actually early androgenetic loss.
Lowering a hairline creates a permanent commitment. A very low or straight design can consume a large number of grafts and may look inappropriate as the face matures. The proposed line should work with the patient’s likely future appearance rather than copy a photograph from another person.
Stable areas of traction alopecia, burns, trauma or surgical scarring can sometimes be treated. Candidacy depends on whether the damaging cause has stopped, the tissue has adequate blood supply and the scar can support growth. Graft survival and achievable density can be less predictable in scar tissue, so conservative placement or a small test session may be considered.
Continued tight hairstyles, repeated tension or active inflammation must be addressed first. Moving hair into an area that remains exposed to the original cause does not solve the underlying problem.
Telogen effluvium is a diffuse shedding process that may follow illness, major stress, nutritional deficiency, hormonal change, childbirth, medication changes or other triggers. It can overlap with pattern hair loss, but transplantation is not normally the first response to a recent unexplained shed.
The priority is to identify the cause, allow time for recovery and assess what permanent pattern remains. Operating while density is changing can lead to unnecessary graft placement and an inaccurate long-term plan.
Alopecia areata is an autoimmune form of hair loss. The NHS notes that hair transplantation is usually unsuitable for this condition. Because activity and recurrence can be unpredictable, simply filling a patch does not remove the disease process.
Anyone with suspected alopecia areata should receive a dermatological diagnosis rather than rely on a surgical sales assessment. Rare individual circumstances require specialist judgement, but this should not be presented as a routine transplant indication.
Conditions such as lichen planopilaris, frontal fibrosing alopecia and other cicatricial alopecias can permanently damage follicles. Transplantation into active disease is generally avoided because inflammation may destroy existing or implanted follicles and surgery may aggravate the condition.
Selected patients with a confirmed diagnosis and prolonged clinical stability may sometimes be considered by a specialist. Even then, counselling should cover uncertain graft survival, recurrence and the possibility of a test area before a larger procedure. “No redness today” is not enough to declare a scarring condition inactive.
Diffuse unpatterned alopecia, often abbreviated to DUPA, involves miniaturisation throughout the scalp, including areas normally expected to serve as permanent donor hair. If the proposed donor is itself unstable, moving those follicles does not create a dependable result and harvesting can make the back and sides look thinner.
This is one reason donor trichoscopy is important. A dense-looking donor in a distant photograph can still contain significant miniaturisation.
“Stable” does not mean that no hair will ever be lost again. Androgenetic alopecia is progressive. It means the current condition has been investigated well enough to design a result that can remain coherent as ageing and further loss occur.
Warning signs that may justify delay or medical review include:
A clinic should not interpret every delay as lost business. Sometimes the safest and most useful decision is to document the scalp, treat an active problem and reassess after an appropriate interval.
Transplanted hair can remain while untreated native hair around it becomes progressively thinner. Without a long-term design, the result may develop a dense front island, an exposed gap behind the hairline or a crown that consumes donor hair needed elsewhere.
A responsible plan considers more than the area visible today. It asks what the pattern might look like in five, ten or twenty years, how much donor reserve should remain and whether the proposed hairline would still be natural with more extensive loss.
The donor area is not an unlimited bank of replacement hair. FUE removes follicular units one by one, and the extracted units do not grow back at those extraction points. FUT removes a strip of donor-bearing scalp and leaves a linear scar. Both methods redistribute a finite resource.
A proper donor assessment looks beyond the total number advertised by a clinic. It should consider:
Two people with the same number of follicular units per square centimetre can have different cosmetic potential. One may have a greater proportion of two- and three-hair units, coarse shafts and a useful wave. The other may have mostly single units, fine straight hair and strong contrast with the scalp.
The first donor may create more visual coverage from the same graft count. This does not make fine hair untreatable; it changes the achievable result and the way grafts should be distributed.
Not all hair at the back and sides is equally likely to remain. Harvesting too high, too low or too far forward can take follicles from less stable zones. This may leave visible dot scarring and transplanted hairs that thin later.
Safe boundaries differ between patients. A pre-drawn rectangular extraction area should not be applied identically to everyone. The surgeon needs to examine the pattern, family history and miniaturisation rather than assume that every visible follicle is permanent.
Miniaturisation means some follicles are producing progressively finer hairs. It is assessed by close scalp examination, often with magnification or trichoscopy. A significant variation in shaft diameter or widespread miniaturisation can indicate that the apparent donor density is less reliable than it looks.
Ignoring donor miniaturisation can produce two problems: weak grafts may not provide durable coverage, and extraction can unmask thinning in the donor region.
Patients seeking a second session or repair need an especially careful donor inventory. The original operation may have reduced density unevenly, left a wide linear scar, harvested outside safe boundaries or used an unknown number of grafts.
The assessment should map existing scars, estimate remaining capacity and identify whether the priority is adding density, softening an unnatural hairline, redistributing plugs, concealing scars or correcting overharvesting. Repair cases are not simply first procedures with a smaller donor.
If scalp donor cannot support the requested coverage, appropriate options may include a higher or more mature hairline, concentrating grafts in the frontal zone, accepting lower density, staging treatment, using camouflage or choosing no surgery.
Beard hair can supplement scalp grafts in selected cases, particularly in repair or advanced loss, but it differs in texture and growth behaviour. It should not be used to justify unsafe scalp harvesting or marketed as an unlimited substitute.
Candidacy also depends on where the grafts will be placed. The clinician should examine scalp thickness, scarring, inflammation, blood supply, existing miniaturised hair and the size of the recipient surface.
A small frontal zone with strong donor characteristics may offer a favourable balance. A very large front-to-crown area with weak donor supply may allow only strategic coverage. The fact that grafts can physically be implanted across a surface does not mean that high density is safe or achievable.
Significant dermatitis, infection, folliculitis, psoriasis flare or unexplained inflammation should be assessed and treated before elective surgery. The exact approach depends on the diagnosis. Patients should not try to hide symptoms with cosmetic products for the consultation, because the scalp examination is part of the safety assessment.
Scar tissue can have altered vascularity and may not tolerate the same recipient density as healthy scalp. In uncertain cases, a small test session followed by adequate observation may be more responsible than a large one-stage promise.
There is no universal age at which everyone becomes suitable, and there is no fixed upper age limit that automatically excludes a healthy patient. Age matters because it changes the amount of information available about future loss, health risks and aesthetic goals.
A person in their late teens or early twenties can have genuine distress and real androgenetic alopecia, but their eventual pattern may be difficult to predict. Creating a low juvenile hairline in an early stage can consume donor supply before the full extent of loss becomes clear.
Young age is not an automatic prohibition. It increases the need for:
A clinic that uses urgency—“do it now before you lose more”—instead of long-term planning deserves caution.
Older age alone does not prevent a good result. In some respects, an established pattern can make planning more predictable. Suitability still depends on donor quality, scalp health, medical fitness and goals.
An older patient requesting modest frontal improvement may be a stronger candidate than a much younger person asking for a dense teenage hairline. Chronological age is only one part of the assessment.
The core principles are the same for all patients, but the pattern and donor assessment may differ.
Men often retain a band of denser hair around the back and sides while thinning develops at the temples, front, mid-scalp or crown. When that donor band is stable and the proposed design is conservative, transplantation can provide a durable cosmetic improvement.
The Norwood stage alone does not determine suitability. A man with moderate visible loss and extensive donor miniaturisation may be a poor candidate, while someone with more advanced loss but a strong donor may be suitable for carefully prioritised coverage.
Women often experience diffuse thinning across the central scalp with preservation of the frontal edge, although patterns vary. Some also have thinning within the potential donor area. If the donor is not clearly stronger and more stable than the recipient, surgery may offer limited benefit.
Women can be good candidates when loss is diagnosed, the donor region is suitable and the target area is clearly defined. Examples can include selected female-pattern loss, a stable high hairline, traction alopecia after the cause has ended or reconstruction of a localised scar.
Because diffuse shedding can have many contributors, the evaluation may include medical history and targeted investigations where clinically indicated. A clinic should not automatically attribute every woman’s thinning to genetics or offer surgery before considering other causes.
Candidacy is not limited to one hair type or ethnicity. Straight, wavy, curly and tightly curled hair can all be transplanted, but their characteristics affect coverage, extraction and handling.
These factors influence the surgical plan; they should never be used to promise a specific result from a graft count alone. Patients with Afro-textured hair should ask for evidence of the team’s experience with curved follicles and similar hair characteristics.
A hair transplant is usually performed under local anaesthesia, sometimes with sedation, but it remains a surgical procedure. Medical history matters even when the patient is awake and the operation is marketed as minimally invasive.
Having a chronic condition does not automatically make someone unsuitable. The question is whether it is diagnosed, controlled and compatible with the proposed procedure, medicines, duration and setting.
Diabetes may affect wound healing and infection risk, especially when poorly controlled. A patient with diabetes may still be considered after individual review, appropriate control and, when needed, communication with the treating doctor. A clinic should not give a universal approval based only on a message saying “my diabetes is fine”.
Blood pressure, heart history and relevant medication should be reviewed. Anxiety, long procedure times and medicines used during surgery can be relevant. Patients with significant cardiovascular disease may require medical clearance or a different surgical setting.
A history of abnormal bleeding, clotting problems or use of anticoagulants, antiplatelet drugs and some supplements must be disclosed. Do not stop prescribed medication because a clinic salesperson tells you to. Any change should be agreed with the prescribing clinician and surgical doctor after weighing bleeding and clotting risks.
Autoimmune disease does not have one universal answer. Suitability depends on the diagnosis, activity, medication, scalp involvement and healing risk. Dermatology input can be important when the hair loss itself may be inflammatory or autoimmune.
Report known allergies, previous reactions to local anaesthetic, adhesives, antibiotics, antiseptics and other medicines. A vague intake form completed on the morning of surgery is not an adequate substitute for medical review.
Nicotine can constrict blood vessels and may impair healing. Smoking also adds wider health risks. The clinic should provide an individual cessation policy and explain it before booking, not after the patient arrives. Be honest about cigarettes, vaping and nicotine products so the team can assess risk accurately.
Hair transplantation is elective and is generally deferred during pregnancy. Postpartum shedding can also change the apparent pattern. Breastfeeding introduces additional medication and timing considerations. A patient in either situation should discuss the timing with their own doctor rather than rely on a cosmetic package schedule.
There is no single laboratory panel that proves candidacy for everyone. Testing should be based on the patient’s history, examination, local standards, planned anaesthesia and suspected causes of loss. Some clinics routinely request blood count, clotting or infection screening; others add targeted investigations when indicated.
A long list of normal tests does not replace a correct hair-loss diagnosis, and a transplant should not be sold as treatment for an unexplained abnormal result.
Hair loss can affect confidence and quality of life. Wanting improvement is not itself a psychological warning sign. The concern is whether expectations, distress or compulsive behaviour make it unlikely that any technically successful result will feel acceptable.
A good candidate generally understands that:
Body dysmorphic disorder involves persistent, impairing preoccupation with perceived appearance flaws. Warning signs can include repeated procedures with continuing dissatisfaction, spending hours checking or concealing a minor feature, inability to accept normal variation, or believing that surgery will solve every social or professional difficulty.
Research in hair-restoration patients supports screening for psychological risk and unrealistic expectations. When significant concern is identified, postponing surgery and seeking mental-health assessment is a safety measure, not a dismissal of the person’s distress.
The decision should belong to the patient. Pressure from a partner, social media, an employer, a clinic discount or a sales representative is not a good reason to proceed. A candidate should have time to understand the plan and change their mind before surgery.
Being a candidate for hair transplantation does not automatically mean every method is equally suitable. The extraction approach, hairstyle, donor characteristics, scarring preference, graft requirement and future plan all matter.
FUE may suit patients who prefer very short hairstyles, want to avoid a linear donor scar or need a smaller, targeted session. It creates many small extraction scars rather than “scarless” surgery. Excessive or poorly distributed extraction can leave moth-eaten thinning.
A stable donor area with sufficient density and appropriate follicle characteristics is essential. Curl, previous extraction and the size of the session can increase technical demands.
FUT may suit selected patients who accept a linear scar, have appropriate scalp laxity and want to preserve more of the wider donor zone for future planning. It can be efficient for larger graft requirements, but scar behaviour and healing vary.
A patient who routinely shaves the donor very short may find the linear scar difficult to conceal. A history of wide or raised scars also deserves discussion.
DHI generally describes implantation with a pen-style implanter, while “Sapphire FUE” generally refers to recipient sites made with sapphire blades. Neither label creates a new donor supply or changes the diagnosis. Extraction is still usually FUE.
A patient is not a good candidate merely because a clinic assigns them to a branded package. Surgeon involvement, donor safety, hairline design, graft handling and team competence matter more than the marketing term. See our FUE, DHI, Sapphire FUE and FUT comparison for a detailed explanation.
The crown can require many grafts because of its circular area and whorl pattern. A patient with a small crown and stable front may be suitable, but someone with early frontal thinning may need to reserve grafts for higher-impact areas. Crown goals should be discussed in the context of total lifetime supply.
Repair may involve softening a pluggy hairline, correcting direction, adding density, camouflaging scars or improving an overharvested donor. The best option could include graft removal, redistribution, scalp micropigmentation, conservative additional transplantation or accepting that complete correction is impossible.
Patients should obtain the previous operation report and graft count if available. Clear photographs from before and after earlier surgery can also help the repair surgeon understand what changed.
Stable scars from injury or surgery may accept grafts, but blood supply, scar thickness, colour and surrounding density affect the outcome. A staged approach may be appropriate. Camouflage should be planned for normal viewing conditions, not only for close-up photographs.
Eyebrow and beard restoration require diagnosis and very careful control of angle, direction and hair selection. Scalp donor hair placed in an eyebrow may continue to grow like scalp hair and require trimming. Patchy beard loss caused by active alopecia areata is different from a stable congenital gap or scar.
Advanced loss does not automatically exclude surgery, but it makes prioritisation essential. A strong donor may support a mature frontal frame and lighter mid-scalp coverage while leaving the crown thin. A weak donor may not justify surgery at all.
A candidate who accepts strategic coverage can be more suitable than someone with less hair loss who insists on dense full coverage and a low hairline.
A thorough assessment should connect diagnosis, measurements, design and risk. It should not begin and end with a graft quotation sent through a messaging app.
The clinician should ask about when loss began, speed of progression, family pattern, symptoms, past treatments, operations, illnesses, medications, allergies, smoking and healing history. Women may need questions about cycle changes, pregnancy, menopause and signs that point to hormonal or nutritional contributors.
The examination should assess the distribution of loss, scalp condition, donor boundaries, density, calibre, follicular groupings and miniaturisation. Magnified examination or trichoscopy can reveal differences that ordinary photographs miss.
Clear photographs from consistent angles and lighting document the starting point and help with long-term monitoring. Wet and dry views can reveal different aspects of density. Images should support examination, not replace it.
The proposed hairline and treatment zones should be drawn and explained. Ask which areas are being prioritised, which will remain lighter and how the design changes if future loss progresses.
The clinic should explain the basis for its estimate and the safe harvesting strategy. A precise number from a few photographs can create false confidence. A clinically responsible quotation may provide a range that is confirmed after in-person assessment.
The patient should know who diagnoses the condition, designs the hairline, administers anaesthesia, makes recipient sites, extracts grafts and implants them. The person selling the package should not be the only source of medical answers.
Our guide to choosing a hair transplant clinic in Turkey provides a full verification checklist. If you are travelling, also review the hair transplant safety guide before paying a deposit.
Medical treatment can be useful before or after surgery for selected patients with pattern hair loss. The aim may be to preserve native hair, improve miniaturised follicles, clarify the stable pattern or reduce the risk of an isolated transplanted zone.
Medication is not compulsory for every patient, and it is not risk-free. Suitability, contraindications and side effects should be discussed with a qualified clinician. Do not start, stop or purchase prescription treatment solely because a transplant package requires it.
When the pattern is rapidly changing, a period of documented treatment and observation may make the eventual surgical plan more accurate. It can also reveal that the patient is satisfied without surgery or that a smaller procedure is sufficient.
This checklist cannot diagnose you, but it can help you prepare for a consultation.
If several answers are “no” or “I do not know”, the next step is better assessment, not a faster booking.
| Green flags | Amber flags | Red flags |
|---|---|---|
| Diagnosis and donor findings are explained | Only photographs have been reviewed so far | No medical history or scalp diagnosis |
| A graft range is linked to a treatment map | Exact count promised before examination | “Unlimited grafts” or mandatory maximum extraction |
| Future loss and reserve are discussed | Future loss mentioned without a plan | Very low hairline despite early progressive loss |
| Doctor’s role is clear | Answers come mainly from a coordinator | Responsible clinician cannot be identified |
| Risks and alternatives are provided | Complications are minimised | Guaranteed result or “no risk” claim |
| You have time to decide | Short discount deadline | Pressure to pay before medical review |
An amber flag is a prompt to obtain more information. A red flag is a reason to pause and consider another provider or an independent medical opinion.
A responsible clinic may recommend delay when:
Delay does not necessarily mean “never”. It can provide time for diagnosis, treatment, documentation or reconsideration. In some cases, however, the most ethical recommendation is not to operate. A clinic’s willingness to refuse an unsuitable case can be a sign of medical judgement rather than poor service.
Ask for answers in writing where possible. This makes it easier to compare plans rather than package names. You can browse our Turkey hair transplant clinic directory, but a listing should be the beginning of your research, not a substitute for independent verification.
The size of the bald area does not create donor supply. Advanced loss may be treatable with strategic coverage, but some patients do not have enough stable donor hair for a worthwhile result.
Hair length, lighting and styling can conceal miniaturisation or old extraction. Magnified examination and measurements are more informative than appearance alone.
FUE leaves small extraction scars and permanently reduces follicular density at the extraction points. Candidacy and safe distribution still matter.
An implantation pen cannot turn unstable or insufficient donor hair into a strong supply. DHI describes an implantation approach, not a solution to poor candidacy.
More grafts can improve coverage only when they are safely available, handled well and placed according to a coherent plan. Overharvesting can permanently damage the donor appearance.
Age alone is not a universal exclusion. An older, medically fit patient with a stable pattern and realistic goal may be a good candidate.
Youth does not compensate for an evolving pattern or an overly aggressive design. Long-term planning is especially important when the eventual loss is uncertain.
You need a clear hair-loss diagnosis, a suitable and stable donor area, a recipient zone likely to benefit, medical fitness and realistic expectations. An in-person scalp and donor examination is the most reliable way to confirm these factors.
Photographs and video can support preliminary screening, especially for travel planning, but they cannot reliably measure donor miniaturisation, scalp disease, tissue quality or every medical risk. Treat an online opinion as provisional until examination.
There is no universal minimum that makes all patients suitable on their birthday. Very young adults require greater caution because the future pattern may be unclear. Diagnosis, progression, donor findings and a conservative long-term design are more important than a single number.
There is no automatic upper age limit. General health, medications, donor quality, healing capacity and realistic goals determine suitability. Medical clearance may be appropriate for some older patients.
Yes, selected women can be good candidates. The cause of thinning and stability of the donor area are crucial because some women have diffuse miniaturisation that includes the back and sides.
Possibly, but the plan must account for progression. Rapid or unexplained change may justify treatment and observation before surgery. Stable patterned loss can sometimes be transplanted while ongoing native hair is managed separately.
A mildly limited donor may support a smaller, prioritised procedure, but diffuse miniaturisation or severe depletion may make surgery unsuitable. Changing the implantation technique does not repair inadequate donor capacity.
Grey hair is not an exclusion. In some patients, lower contrast with the scalp can improve the appearance of coverage. The clinician may use temporary colouring or magnification to make pale follicles easier to see during parts of the procedure.
Yes. Curl can provide strong visual coverage, but curved follicles can make extraction more technically demanding. Choose a team with documented experience in similar hair and skin characteristics.
Not automatically. The type of diabetes, level of control, complications, medicines and healing risk require individual assessment. Poorly controlled disease may lead to delay or a recommendation against elective surgery.
This requires review by the surgical doctor and the clinician who prescribed the medication. Never discontinue anticoagulant or antiplatelet treatment on your own, because stopping it can be dangerous.
Not every candidate must use medication. It may be recommended to stabilise or preserve native hair in selected cases. Benefits, risks and alternatives should be considered individually.
Hair transplantation is usually unsuitable for alopecia areata because the autoimmune condition can remain active or recur. Dermatological assessment should come before any surgical proposal.
Active scarring alopecia is generally not transplanted. Carefully selected, long-stable cases may sometimes be considered by specialists, often with cautious density or test grafting, but growth and recurrence can be less predictable.
Ask each clinic to explain its diagnosis, donor measurements, risk assessment and long-term plan. A refusal may reflect a genuine safety or expectation concern. If opinions differ substantially, obtain an independent dermatology or hair-restoration assessment rather than choosing the most optimistic sales offer.
No. Good candidacy improves the basis for treatment but cannot eliminate variation in healing, graft growth, scarring, infection risk, future loss or aesthetic judgement. Technique and aftercare also matter.
Transplanted shafts commonly shed before new growth becomes visible. Change develops gradually over months, and maturation can continue for a year or longer, particularly in the crown. Your clinic should give a case-specific follow-up schedule rather than promise an instant transformation.
No. Choose a clinic that explains the safe number for your donor, treatment priorities and future reserve. “Maximum grafts” is not a medical plan. Read our Turkey hair transplant cost guide before comparing package offers.
A good hair transplant candidate is not simply someone with hair loss and enough money for a package. The strongest cases combine a confirmed diagnosis, a stable and measurable donor supply, a healthy recipient scalp, acceptable medical risk, achievable goals and a design that respects future loss.
The decision should answer four questions: What is causing the loss? Which hairs are safe to move? What can the available donor realistically achieve? Will the plan still look natural if more hair is lost?
If a clinic cannot explain those points, do not let a technique name or discount make the decision for you. Start with assessment, compare written plans and be prepared to delay surgery when the diagnosis or donor is uncertain.
For the wider process, read our complete hair transplant in Turkey guide and step-by-step hair transplant procedure guide.
Medical disclaimer: This article provides general educational information and is not a diagnosis or personal surgical recommendation. Hair loss, donor capacity, medical fitness and treatment options must be assessed by appropriately qualified clinicians. Do not start or stop prescribed medicines based on this guide.